ACRP blog

JANUARY 10, 2024

Views from ACRP Members Topics highlighted include diversity and inclusion, decentralized clinical trial (DCT) elements, workforce challenges, and a possible role for sponsors and contract research organizations (CROs) in supporting outreach by sites based in diverse communities. Nadege Gunn: Need for study-agnostic funding for sites in diverse areas “The need for improved diversity of all kinds among trial participants will continue in 2024, with sponsor and CRO support critical to success,”

Clinical Trials 64

Clinical Trials Clinical Trials Trials Clinical Research 64

XTalks

JANUARY 8, 2024

Getting a drug to market used to be a relatively simple and straightforward affair. That’s just not the case anymore. Whether it’s for a treatment for a chronic ambulatory condition, precision medicine or cell and gene therapy, there is a massive uptick in clinical trial complexity. Most Phase II and Phase III studies have around 20 endpoints and 263 procedures per patient.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Gene Therapy 105

Outsourcing Pharma

JANUARY 10, 2024

Global contract research organization (CRO), Fortrea today announced an industry partnership with founding members cloud solutions company Veeva Systems Inc., and provider of clinical research technology, Advarra.

Clinical Trials 80

Clinical Trials Clinical Trials Clinical Research Trials 80

Outsourcing Pharma

JANUARY 9, 2024

Medable Inc. has announced a new intelligent automation technology applied across its clinical trials platform it hopes will cut standard trial build timelines by at least half.

Clinical Trials 102

Clinical Trials Clinical Trials Trials Clinical Development 102

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

Rethinking Clinical Trials

JANUARY 8, 2024

In a new article from the NIH Pragmatic Trials Collaboratory, investigators from 6 of the program’s pragmatic clinical trials share case examples of the challenges they encountered in collecting patient-reported outcomes (PROs) in their trials and the strategies they used to address them. The article was published this week in Contemporary Clinical Trials.

Trials 298

Trials Clinical Trials Clinical Trials Research 298

CTTI (Clinical Trials Transformation Initiative)

JANUARY 9, 2024

Today, the U.S. Food and Drug Administration (FDA) and the Clinical Trials Transformation Initiative (CTTI) announced eight newly selected representatives for the Patient Engagement Collaborative (PEC). The group of 16 patients, caregivers, and patient group representatives meets with the FDA several times a year and discusses a variety of topics such as improving communication, education, and patient engagement related to medical product regulation.

Clinical Trials 124

Clinical Trials Clinical Trials Trials Regulation 124

Imperical Blog

JANUARY 9, 2024

Diversity in clinical trials is becoming mandatory, which can make drugs and devices more widely beneficial. New FDA regulations are coming; read on for our understanding of what to expect. Right now, almost a half million studies are registered on ClinicalTrials.gov, and about 65,000 are… The post Pending FDA Clinical Trial Diversity Requirements appeared first on Imperial Clinical Research Services Blog.

Clinical Trials 59

Clinical Trials Clinical Trials Trials Clinical Research 59

Rethinking Clinical Trials

JANUARY 11, 2024

In a new article from the NIH Pragmatic Trials Collaboratory, the BeatPain Utah study team describes the "implementation mapping" they used to plan for trial implementation. The comprehensive, systematic approach enabled the team to craft an implementation plan for a complex telehealth intervention and to identify outcomes for evaluating the success of the implementation strategies.

Trials 147

Trials Clinical Trials Clinical Trials Nurses 147

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 9, 2024

Experts in the life-sciences industry are of the view that doing away with human studies for new drugs in India is unscientific and risky as patients here have different anthropometry.

Trials 173

Trials Life Science Clinical Trials Clinical Trials 173

Bio Pharma Dive

JANUARY 12, 2024

Arena BioWorks, which will be led by Harvard University scientist Stuart Schreiber, seeks to blend academic and venture capital drug research models.

Scientist 328

Scientist Drugs Research 328

Advertisement

Clinical Supply

Pharmaceutical Technology

JANUARY 8, 2024

With micronisation required for 30% of APIs on the market, there is a need for more sustainable methods of milling these vital drug products.

Production 263

Production Marketing Drugs 263

Rethinking Clinical Trials

JANUARY 9, 2024

          Speaker Speaker: Rui Wang, PhD Associate Professor of Population Medicine and Associate Professor in the Department of Biostatistics, Harvard Pilgrim Health Care Institute and Harvard Medical School Moderator: Fan Li, PhD Assistant Professor of Biostatistics, Yale School of Public Health Slides Keywords Cluster-randomized; Intervention; Missingness; Outcomes Key Points Cluster randomized trials are trials in which clusters of individuals rather than independent individuals ar

Trials 220

Trials Clinical Trials Clinical Trials Research 220

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 9, 2024

It seems the time that wounds take to heal is partly down to mentality: researchers have found that healing happens faster when the person involved thinks that time is progressing more quickly than it actually is.

Research 246

Research Clinical Trials Clinical Trials Clinical Research 246

Bio Pharma Dive

JANUARY 9, 2024

Albert Bourla acknowledged Pfizer’s difficult 2023, while a biotech CEO spoke with BioPharma Dive about building neuroscience startups.

321

321

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

Pharmaceutical Technology

JANUARY 12, 2024

Cereno Scientific has announced a partnership with CordenPharma to scale up manufacture of its drug candidate CS1.

Production 246

Production Drugs Manufacturing 246

Rethinking Clinical Trials

JANUARY 10, 2024

In this Friday's PCT Grand Rounds, Erin McCreary of the University of Pittsburgh will present "Design and Implementation of a Weighted Lottery to Equitably Allocate Scarce COVID-19 Resources." The Grand Rounds session will be held on Friday, January 12, 2024, at 1:00 pm eastern. McCreary is a clinical assistant professor of medicine at the University of Pittsburgh and the director of infectious diseases improvement and clinical research innovation at UPMC.

Clinical Trials 195

Clinical Trials Clinical Trials Clinical Research Medicine 195

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 10, 2024

Those trying to kick-start their weight loss or perhaps wanting to lose a few pounds before a big event or holiday may be tempted to try a crash diet.

Clinical Trials 242

Clinical Trials Clinical Trials Clinical Research Trials 242

Bio Pharma Dive

JANUARY 8, 2024

The chip maker struck a new deal with Amgen on Monday, while Sarepta brought news of strong sales to the J.P. Morgan Healthcare Conference.

Sales 321

Sales 321

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Pharmaceutical Technology

JANUARY 8, 2024

The FDA has granted approval for Ligand Pharmaceuticals’ Zelsuvmi (berdazimer topical gel, 10.3%) for molluscum contagiosum.

246

246

Rethinking Clinical Trials

JANUARY 9, 2024

Ethics and regulatory onboarding documentation is now available for iPATH, one of the NIH Pragmatic Trials Collaboratory's newest pragmatic clinical trials. The documents include meeting minutes and supplementary materials summarizing recent discussions of ethics and regulatory issues associated with the study. The consultation took place by video conference and included representation from the study's principal investigator and study team, members of the NIH Collaboratory's Ethics and Regulator

Trials 147

Trials Clinical Trials Clinical Trials 147

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 8, 2024

It’s a familiar start-of-the-year scene. You’ve committed to a healthier lifestyle and are determined that this time is going to be different. Your refrigerator is stocked with fruits and veggies, you’ve tossed out processed foods, and your workout routine is written in pen in your daily planner.

Clinical Trials 242

Clinical Trials Clinical Trials Clinical Research Trials 242

Bio Pharma Dive

JANUARY 10, 2024

Many drugmakers hope to compete in obesity, while others seek to win oncology’s next era. In the background, a contentious drug pricing law looms.

Drugs 306

Drugs 306

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

Clinical Research

Pharmaceutical Technology

JANUARY 7, 2024

Novo Nordisk taps Flagship Pioneering portfolio companies Omega Therapeutics and Cellarity as obesity drugs competition intensifies.

Drugs 246

Drugs 246

Pharma Times

JANUARY 11, 2024

The diagnostic system can deliver particles to the lungs via aerosol or a nebuliser

139

139

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 7, 2024

A study suggests eating later in the day can directly impact our biological weight regulation in three key ways: through the number of calories that we burn; our hunger levels; and the way our bodies store fat.

Regulation 238

Regulation Clinical Trials Clinical Trials Clinical Research 238

Bio Pharma Dive

JANUARY 8, 2024

At the J.P. Morgan Healthcare Conference Monday, company head Chris Viehbacher said insurance reimbursement is now ‘not an issue’ for treatment.

Drugs 287

Drugs 287

Advertisement

Clinical Supply

Pharmaceutical Technology

JANUARY 10, 2024

Vertex Pharmaceuticals has announced the approval of CASGEVY (exagamglogene autotemcel [exa-cel]), the first CRISPR/Cas9 gene-edited therapy.

Gene Editing 244

Gene Editing Gene 244

Fierce Pharma

JANUARY 9, 2024

Pfizer knows it had a bad year in 2023. Speaking to reporters at the 2024 J.P. | Pfizer knows it had a bad year in 2023. Speaking to reporters at the 2024 J.P. Morgan Healthcare Conference on Monday, the company’s CEO, Albert Bourla, spoke bluntly about the hits the company took, and he acknowledged the underperformance of certain key launches.

139

139

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 11, 2024

Researchers have identified an entirely new class of antibiotic that can kill bacteria that are resistant to most current drugs. Zosurabalpin is highly effective against the bacterium carbapenem-resistant Acinetobacter baumannii (Crab), which is classified as a “priority 1” pathogen by the World Health Organization due to its growing presence in hospitals.

Bacterium 230

Bacterium Bacteria Drugs Research 230

Bio Pharma Dive

JANUARY 8, 2024

The acquisition will build out Merck’s pipeline of immunotherapies as its top-seller Keytruda nears the end of U.S. market exclusivity.

Marketing 278

Marketing 278

Advertisement

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

Clinical Trials